Stockholder Notice: Robbins LLP Informs Stockholders of Caribou Biosciences, Inc. of the Class Action Lawsuit
Published on December 30, 2024
having insufficient cash, liquidity, and/or other capital to fund its current business operations, including preclinical research activities